Technical Analysis for ALDR - Alder BioPharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 9.59 3.68% 0.34
ALDR closed up 3.68 percent on Friday, August 16, 2019, on 58 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical ALDR trend table...

Date Alert Name Type % Chg
Spinning Top Other 0.95%
Narrow Range Bar Range Contraction 0.95%
NR7 Range Contraction 0.95%
Inside Day Range Contraction 0.95%
MACD Bullish Signal Line Cross Bullish -2.24%
180 Bearish Setup Bearish Swing Setup 2.24%
1,2,3 Retracement Bearish Bearish Swing Setup -4.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.00%
Earnings Movers Other -4.00%
Multiple of Ten Bearish Other -4.00%

Older signals for ALDR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Alder Biopharmaceuticals Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes various therapeutic antibodies in the United States and Australia. It is developing monoclonal antibodies comprising ALD403, which has completed Phase Ib proof-of-concept trials to target calcitonin gene-related peptide for the prevention of migraine; and Clazakizumab that has completed Phase IIb clinical trials that inhibits the pro-inflammatory cytokine interleukin-6 in the treatment of rheumatoid arthritis and psoriatic arthritis. The company also has preclinical programs in the discovery phase for various indications. Alder Biopharmaceuticals Inc. has a collaboration with Bristol-Myers Squibb Company for the development of Clazakizumab. Alder Biopharmaceuticals Inc. was incorporated in 2002 and is headquartered in Bothell, Washington.
Medicine Health Biotechnology Biopharmaceutical Immunology Antibodies Monoclonal Antibodies Rheumatoid Arthritis Bristol Myers Squibb Migraine Prevention Of Migraine Psoriatic Arthritis
Is ALDR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 18.95
52 Week Low 8.65
Average Volume 814,135
200-Day Moving Average 12.1281
50-Day Moving Average 10.75
20-Day Moving Average 9.831
10-Day Moving Average 9.469
Average True Range 0.4811
ADX 31.92
+DI 18.4222
-DI 28.8917
Chandelier Exit (Long, 3 ATRs ) 9.2267
Chandelier Exit (Short, 3 ATRs ) 10.0933
Upper Bollinger Band 10.8195
Lower Bollinger Band 8.8425
Percent B (%b) 0.38
BandWidth 20.109857
MACD Line -0.3709
MACD Signal Line -0.4013
MACD Histogram 0.0304
Fundamentals Value
Market Cap 649.37 Million
Num Shares 67.7 Million
EPS -5.14
Price-to-Earnings (P/E) Ratio -1.87
Price-to-Sales 1026.10
Price-to-Book 2.38
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.31
Resistance 3 (R3) 10.30 10.05 10.19
Resistance 2 (R2) 10.05 9.87 10.06 10.15
Resistance 1 (R1) 9.82 9.75 9.94 9.83 10.11
Pivot Point 9.57 9.57 9.63 9.58 9.57
Support 1 (S1) 9.34 9.39 9.46 9.35 9.07
Support 2 (S2) 9.09 9.27 9.10 9.03
Support 3 (S3) 8.86 9.09 8.99
Support 4 (S4) 8.87